Middletown, DE -- (SBWIRE) -- 10/09/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Invivo Therapeutics Holdings Corp(OTCMKTS:NVIV), Pfizer Inc.(NYSE:PFE) , Affymax, Inc.(OTCMKTS:AFFY) , Microsoft Corporation(NASDAQ:MSFT)
Invivo Therapeutics Holdings Corp(OTCMKTS:NVIV) opened the session at $1.45, remained amid the day range of $1.42 - $1.55, and recently traded at $1.51. The stock showed a positive performance of 4.86% in the recent trading session. The stock gained a volume of 235,815.00 shares and the average volume of the stock remained 1.11 million shares. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
What was the Moving Force behind NVIV On Bullish Run? Read This Research Report on NVIV
Pfizer Inc.(NYSE:PFE) traded with volume of 17.20 million shares in the recent trading session and the average volume of the stock remained 24.89 million shares. The 52 week range of the stock remained $23.35 - $31.15. The stock showed a positive movement of 0.12% and was recently trading at $28.27. The market capitalization of the stock remained 187.29 billion. Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer?s disease, cardiovascular, erectile dysfunction.
For How Long PFE will Fight for Profitability? Read This Trend Analysis report
Affymax, Inc.(OTCMKTS:AFFY) exchanged 833,819.00 shares and the average volume remained 715,736.00 shares. The stock dropped -5.74% and was moving at $1.15. The beta of the stock remained +1.56 and the EPS of the stock remained -2.82. The shares outstanding of the stock remained 37.49 million. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Why Should Investors Buy AFFY After theRecentFall? Just Go Here and Find Out
Microsoft Corporation(NASDAQ:MSFT) gained volume of 20.21 million shares, while the average volume remained 55.85 million shares. The stock advanced 0.69% and remained at $33.24. The EPS of the stock remained +2.59. Microsoft Corporation (Microsoft) develops, licenses, and supports software, services, and hardware devices worldwide. Its Windows division offers Windows operating system; Windows Services suite of applications and Web services, including Outlook.com and SkyDrive; Surface RT and Pro devices; and PC accessories.
Will MSFT Continue To Move Higher? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)